GH1 and acromegaly: Chronic exposure to elevated GH and IGF-I levels in patients with acromegaly is associated with considerable comorbidities such as metabolic dysfunction leading to an increased risk of diabetes mellitus and, if left untreated, increased mortality related to cardiovascular, cerebrovascular, and pulmonary dysfunction (2, 3).